Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic preconditioning.
Although it is well documented that neutrophils are critical for the delayed phase of hepatic ischemia-reperfusion injury, there is no direct evidence for a specific neutrophil-derived oxidant stress in vivo. Therefore, we used a model of 60 min of partial hepatic ischemia and 0-24 h of reperfusion to investigate neutrophil accumulation and to analyze biomarkers for a general oxidant stress [glutathione disulfide (GSSG) and malondialdehyde (MDA)] and for a neutrophil-specific oxidant stress [hypochlorite (HOCl)-modified epitopes] in rats. Plasma alanine transaminase activities and histology showed progressively increasing liver injury during reperfusion, when hepatic GSSG and soluble MDA levels were elevated. At that time, few neutrophils were present in sinusoids. However, the number of hepatocytes positively stained for HOCl-modified epitopes increased from 6 to 24 h of reperfusion, which correlated with the bulk of hepatic neutrophil accumulation and extravasation into the parenchyma. Consistent with a higher oxidant stress at later times, hepatic GSSG and protein-bound MDA levels further increased. Treatment with the NADPH oxidase inhibitor diphenyleneiodonium chloride attenuated postischemic oxidant stress (GSSG, protein-bound MDA, and hepatocytes positively stained for HOCl-modified epitopes) and liver injury at 24 h of reperfusion. Ischemic preconditioning suppressed all oxidant stress biomarkers, liver injury, and extravasation of neutrophils. In conclusion, extravasated neutrophils generate HOCl, which diffuses into hepatocytes and causes oxidative modifications of intracellular proteins during the neutrophil-mediated reperfusion injury phase. Ischemic preconditioning is an effective intervention for reduction of the overall inflammatory response and, in particular, for limitation of the cytotoxic activity of neutrophils during the later reperfusion period.
Liver Research Institute, University of Arizona, Tucson, AZ 85724, USA.
Tadashi
T
Hasegawa
Ernst
E
Malle
Anwar
A
Farhood
Hartmut
H
Jaeschke
D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D000939:Epitopes; D005978:Glutathione / Q000378:metabolism; D006997:Hypochlorous Acid / Q000737:chemistry*; D007150:Immunohistochemistry; D019194:Ischemic Preconditioning; D007958:Leukocyte Count; D008099:Liver / Q000378:metabolism* / Q000473:pathology*; D008297:Male; D008315:Malondialdehyde / Q000378:metabolism; D019255:NADPH Oxidases / Q000037:antagonists & inhibitors; D009336:Necrosis; D009504:Neutrophils / Q000187:drug effects / Q000378:metabolism*; D016877:Oxidants / Q000737:chemistry*; D018384:Oxidative Stress / Q000502:physiology; D011506:Proteins / Q000378:metabolism*; D051381:Rats; D017207:Rats, Sprague-Dawley; D015427:Reperfusion Injury / Q000378:metabolism* / Q000473:pathology*
D000939:Epitopes; D016877:Oxidants; D011506:Proteins; D008315:Malondialdehyde; D006997:Hypochlorous Acid; D019255:NADPH Oxidases; D001219:Aspartate Aminotransferases; D005978:Glutathione